From: Iodine-131 induced hepatotoxicity in previously healthy patients with Grave’s disease
Case 1 | |||||||||
---|---|---|---|---|---|---|---|---|---|
Event | fT3 | fT4 | TSH | Tb | AST | ALT | AKP | δ GT | ALB |
3.5-6.5 pmol/L | 10.2-31.0 pmol/L | 0.35-5.53 mU/L | 3.4-17.1 Umol/L | <40 U/L | <58 U/L | 40–130 U/L | <60 U/L | 34–48 g/L | |
1ST admission 2012-07-11 | 30.0 | 84.0 | 0.02 | 15.1 | 26.1 | 32.8 | 121.5 | 44.6 | 42.0 |
2012-07-25 1st Dose of RAI | |||||||||
7-days post-RAI dose 1 2012-07-31 | 28.0 | 68.0 | 186.0 | 96.0 | 127.0 | 30.0 | |||
After 1-week of liver protection treatment 2012-08-06 | 19.4 | 25.9 | 54.0 | 95.4 | 107.5 | 32.0 | |||
2012-09-02 2nd Dose of RAI | |||||||||
2nd Admission 2012-09-14 | 30.0 | 128.0 | 0.01 | 44.1 | 29.0 | 27.9 | 148.6 | 152.6 | 30.0 |
After 12-days of liver protection treatment 2012-09-25 Discharge | 30.0 | 112.0 | 0.24 | 88.5 | 26.9 | 58.1 | 137.1 | 90.8 | 32.0 |